
Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers
Activated b-catenin or loss of its negative regulator adenomatous polyposis coli (APC) is a potential biomarker for NT219 in the treatment of colorectal cancer NT219’s mechanism of action informs how it can restore efficacy of immunotherapies and expand …